Drug Type Small molecule drug |
Synonyms Compound 18(Smith, Gambrell & Russell) |
Target |
Action stimulants |
Mechanism TREM2 stimulants(Triggering receptor expressed on myeloid cells 2 stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC25H22ClF4N7O2 |
InChIKeyRQFJXGHMXMTHRL-SGTLLEGYSA-N |
CAS Registry3064830-77-6 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Parkinson Disease | Discovery | United Kingdom | 02 Apr 2025 |





